With expertise spanning process, formulation and analytical development to APIs’ manufacturing, clinical trial material and commercial supply, CDMOs offer a wide range of services that benefit sponsors and CROs by leveraging specialized knowledge, technology and infrastructure to bring drugs to market faster.
IDBS offers a GxP-compliant SaaS platform that unifies data and operations, creating a digital backbone for centralized data management—even in decentralized drug development. Aligned with FAIR and ALCOA++ principles, our solutions deliver contextualized, trustworthy data for regulatory submissions and enable early, accurate insights to optimize scalable, robust processes and ensure consistent, high-quality batches.